node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
B3GNT7 | FNIP1 | ENSSSCP00000057113 | ENSSSCP00000015179 | Hexosyltransferase. | Folliculin interacting protein 1. | 0.516 |
B3GNT7 | SLCO4A1 | ENSSSCP00000057113 | ENSSSCP00000034285 | Hexosyltransferase. | Solute carrier organic anion transporter family member. | 0.518 |
FNIP1 | B3GNT7 | ENSSSCP00000015179 | ENSSSCP00000057113 | Folliculin interacting protein 1. | Hexosyltransferase. | 0.516 |
FNIP1 | SLCO4A1 | ENSSSCP00000015179 | ENSSSCP00000034285 | Folliculin interacting protein 1. | Solute carrier organic anion transporter family member. | 0.488 |
SLC10A6 | SLC22A11 | ENSSSCP00000023872 | ENSSSCP00000024675 | Solute carrier family 10 member 6. | Solute carrier family 22 member 11. | 0.527 |
SLC10A6 | SLCO4A1 | ENSSSCP00000023872 | ENSSSCP00000034285 | Solute carrier family 10 member 6. | Solute carrier organic anion transporter family member. | 0.492 |
SLC16A10 | SLCO4A1 | ENSSSCP00000027025 | ENSSSCP00000034285 | Solute carrier family 16 member 10. | Solute carrier organic anion transporter family member. | 0.571 |
SLC16A2 | SLCO4A1 | ENSSSCP00000024224 | ENSSSCP00000034285 | Solute carrier family 16 member 2. | Solute carrier organic anion transporter family member. | 0.670 |
SLC22A11 | SLC10A6 | ENSSSCP00000024675 | ENSSSCP00000023872 | Solute carrier family 22 member 11. | Solute carrier family 10 member 6. | 0.527 |
SLC22A11 | SLCO4A1 | ENSSSCP00000024675 | ENSSSCP00000034285 | Solute carrier family 22 member 11. | Solute carrier organic anion transporter family member. | 0.510 |
SLC22A2 | SLC22A3 | ENSSSCP00000004366 | ENSSSCP00000004365 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 3. | 0.911 |
SLC22A2 | SLC22A4 | ENSSSCP00000004366 | ENSSSCP00000041250 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 4. | 0.931 |
SLC22A2 | SLCO4A1 | ENSSSCP00000004366 | ENSSSCP00000034285 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier organic anion transporter family member. | 0.493 |
SLC22A3 | SLC22A2 | ENSSSCP00000004365 | ENSSSCP00000004366 | Solute carrier family 22 member 3. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.911 |
SLC22A3 | SLC22A4 | ENSSSCP00000004365 | ENSSSCP00000041250 | Solute carrier family 22 member 3. | Solute carrier family 22 member 4. | 0.924 |
SLC22A3 | SLCO4A1 | ENSSSCP00000004365 | ENSSSCP00000034285 | Solute carrier family 22 member 3. | Solute carrier organic anion transporter family member. | 0.561 |
SLC22A4 | SLC22A2 | ENSSSCP00000041250 | ENSSSCP00000004366 | Solute carrier family 22 member 4. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.931 |
SLC22A4 | SLC22A3 | ENSSSCP00000041250 | ENSSSCP00000004365 | Solute carrier family 22 member 4. | Solute carrier family 22 member 3. | 0.924 |
SLC22A4 | SLCO4A1 | ENSSSCP00000041250 | ENSSSCP00000034285 | Solute carrier family 22 member 4. | Solute carrier organic anion transporter family member. | 0.532 |
SLCO4A1 | B3GNT7 | ENSSSCP00000034285 | ENSSSCP00000057113 | Solute carrier organic anion transporter family member. | Hexosyltransferase. | 0.518 |